U.S. House · 117th Congress · H.R. 7515
Infectious Disease Therapies Research and Innovation Act of 2022
To amend the Internal Revenue Code of 1986 to provide an exception from the passive loss rules for investments in specified medical research small business pass-thru entities.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Mike KellyR-PA-16
- Introduced
- April 14, 2022, in the House
- Issue areas
- Policy area
- Taxation (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (2)
2 Republicans. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Vern BuchananR-FL-16
- Brad R. WenstrupR-OH-2